The team at Pinpoint Patient Recruiting is searching for people diagnosed with

stage III or IV endometrial cancer to participate in a paid opportunity to share about their experiences with diagnosis, symptoms, treatments, and impact on daily life.

 

Participation involves:

• a 15-minute phone call with a member of our team to determine if you are eligible to participate

• a 60-minute virtual interview with a healthcare researcher

​

You may qualify if: 

• you have been diagnosed with stage III or IV endometrial cancer and 

• you have changed treatments at least once due to a progression/relapse or the treatment no longer working and

• you are aware of your HER2 expression (HER2+ or HER2-) or you have received Enhertu or Herceptin (currently or previously)

 

Those who qualify and complete the activities will receive a check for $125 as a thank you. 

​

*Please note, you must be a current resident of the US and 18 or older to qualify for and participate in this study. All information shared with Pinpoint will remain confidential.